AMEX · THNR
Amplify Weight Loss Drug & Treatment ETF
$25.95+$0.59 (+2.35%)
Amplify Weight Loss Drug & Treatment ETF’s quoted price sits in the upper half of its reported 52-week range, 7.12% below the high.
Loading market information…
AMEX · BEDZ · USD
Stock price, dividends
Quote as of Aug 21, 2026, 07:52 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
AdvisorShares Hotel ETF’s quoted price sits in the upper half of its reported 52-week range, 4.62% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
AdvisorShares Hotel ETF’s forward annual dividend is $0.46 per share, paid annual. The forward yield is 1.27% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
International travel has experienced a remarkable surge, expanding by a factor of 57 since the emergence of modern tourism in the 1950s, based on data tracking global arrivals. Significant opportunities exist globally, with leading American hotel and accommodation providers extending their reach internationally to tap into diverse income sources. Furthermore, the worldwide travel and tourism sector contributes over 9.1% to the global economy. The Exchange Traded Fund (ETF) framework provides several advantages, such as optimized tax treatment, clear operational visibility, the flexibility of trading throughout the day, enhanced risk mitigation, and the convenience of utilizing limit orders. Following the COVID-19 pandemic, there is substantial pent-up demand, with a striking 88% of American consumers expressing eagerness to resume travel for both professional and personal purposes.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Nov 1, 2026, 06:53 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$25.95+$0.59 (+2.35%)
Amplify Weight Loss Drug & Treatment ETF’s quoted price sits in the upper half of its reported 52-week range, 7.12% below the high.
$13.83+$0.07 (+0.54%)
Genter Capital Dividend Income ETF’s quoted price sits in the upper half of its reported 52-week range, 0.59% below the high.
$23.93-$1.07 (-4.3%)
First Trust Nasdaq Lux Digital Health Solutions ETF’s quoted price sits in the upper half of its reported 52-week range, 4.57% below the high.
$11.93+$0.38 (+3.26%)
Polen Capital Emerging Markets ex China Growth ETF’s quoted price sits in the upper half of its reported 52-week range, 7.82% below the high.
$27.20+$0.18 (+0.67%)
AdvisorShares Restaurant ETF’s quoted price sits in the lower half of its reported 52-week range, 13.97% below the high.
$26.23$0.00 (0.0%)
KraneShares 100% KWEB Defined Outcome January 2027 ETF’s quoted price sits in the lower half of its reported 52-week range, 15.32% below the high.
$27.08-$0.44 (-1.6%)
Ocean Park International ETF’s quoted price sits in the lower half of its reported 52-week range, 8.12% below the high.
$25.71$0.00 (0.0%)
Pacer Developed Markets Cash Cows Growth Leaders ETF’s quoted price sits in the upper half of its reported 52-week range, 4.86% below the high.
